Viral bronchiolitis is the most common cause of admission to hospital for infants in high-
income countries. Respiratory syncytial virus accounts for 60–80% of bronchiolitis …

The coronavirus 2019 (COVID-19) pandemic was caused by a positive sense single-
stranded RNA (ssRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Background Moderate-to-severe asthma remains poorly treated. We evaluated the efficacy
and safety of dupilumab (SAR231893/REGN668), a fully human monoclonal antibody to the …

Respiratory syncytial virus (RSV), a member of the Pneumoviridae family, can cause severe
acute lower respiratory tract infection in infants, young children, immunocompromised …

Interleukin (IL)-33 is a key cytokine involved in type-2 immunity and allergic airway disease.
At the level of lung epithelial cells, where it is clearly expressed, IL-33 plays an important …

Severe respiratory syncytial virus (RSV) infection in infancy is associated with increased risk
of recurrent wheezing in childhood. Both acute and long‐term alterations in airway functions …

Coronavirus disease 2019 (COVID-19) is a worldwide pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) that has affected millions of lives …

Respiratory syncytial virus (RSV) is a frequent cause of respiratory illness among pediatric
and elderly populations. The severity of the respiratory disease is determined, in part, by …

Group 2 innate lymphoid cells (ILC2s), characterized by a lack of antigen receptors, have
been regarded as an important component of type 2 pulmonary immunity. Analogous to Th2 …

Lower respiratory tract infection (LRTI) with respiratory syncytial virus (RSV) is associated
with reduced lung function through unclear mechanisms. In this study, we test the hypothesis …